A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced the presentation of new preclinical data ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only ...

Researchers identified a single protein in cyst nematodes that triggers dozens of the chemical signals called effectors that ...

Bacteria use a newly discovered system called Kongming to turn viral enzymes into a self-destruct signal, with big biotech ...

A new study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

Genocury launched the in vivo CD19 CAR-T therapy to reach the clinical stage, demonstrating exceptional safety, efficiency and durability.